UPC Analytics
ENDE
Analytics1Cases1Decisions4Judges3Parties0Firms
Filing trendsOutcomesPendencyTechnologyForum strategyLeading casesLegal issuesSecurity for costs

Outcome base rates

What's normal — PI grant rate, infringement rate, revocation rate, settlement rate. Honest denominators using motion type.

Legal principlebalance of probabilities test for validity in PI proceedingsClear all
Patentee win rate
Share of merits decisions where the patentee prevailed — infringement cases finding infringement, revocation cases upholding the patent. Settled, withdrawn, and procedural-only outcomes excluded from the denominator.

No merits decisions in the current scope.

PI grant rate
0%
0 granted · 1 denied · 1 total decisions
PI grant rate (conservative)
0%
Granted / total PI decisions (incl. interim, withdrawn)
Infringement rate
—
Revocation rate
—
Settlement / withdrawal rate
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
0% 0 / 1
By technology sector
Top sectors by case count (filter scope applied).
By case category
How outcome rates differ across the six L2 buckets.
  • Provisional measures1
By division
PI grant rate · infringement rate · revocation rate per division (within scope).
  • The Hague LD1 casesPI grant rate: 0%Infringement rate: —Revocation rate: —
Recent decisions
Most recent decisions in scope.
  • 2024-06-19ACT_14945/2024PI deniedApplication for a preliminary injunction by Abbott Diabetes Care Inc. against Sibio Technology Limited and Umedwings Netherlands B.V. concerning EP 3 831 283 (wearable glucose monitoring device) was denied by The Hague Local Division. The court found it more likely than not that claim 1 of the patent would be held invalid for added matter (the claimed feature of a connector support being received through a distal-facing opening into a recess was not directly and unambiguously derivable from the application as filed). As a result, Abbott must bear defendants' costs. Value of the action set at EUR 4,000,000.